Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Turkish women with female pattern hair loss have lower hair density, and visual counting is more effective than digital image analysis for detecting this.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Plant-based treatments can effectively and safely treat hair loss.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.